Digital Therapeutic Development of Virtual Cognitive-Affective Training for Opioid Use Disorder

Digital Therapeutic Development of Virtual Cognitive-Affective Training for Opioid Use Disorder

This is a Phase 1 trial that aims to establish the safety of MORE-VR, as well as to collect feasibility, usability, and engagement data, for patients receiving medications for opioid use disorder (mOUD).

Inclusion Criteria:

• Age 18 or older
• DSM-5 opioid use disorder diagnosis
• treated with medications for opioid use disorder (MOUD)

Exclusion Criteria:

• Mindfulness intervention experience (MBSR, MBRP)
• Active psychosis or high risk of suicidality
• Cognitive impairment (per self-report or report by clinician)
• Unwilling or unable to remain in MOUD treatment for duration of study